These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Menu
Levagen+® is a superior form of PEA with increased bioavailability and format versatility utilizing award-winning LipiSperse® technology, developed by Pharmako Biotechnologies.
Due to its fatty nature, PEA has poor absorption in the body and has limited format options. Lipisperse® reduces surface tension, thereby allowing particles to freely disperse in the watery GIT and/or liquid formats. This results in superior absorption and format breadth.
Published pharmacokinetic studies have demonstrated superiority of Levagen+® with an increased bioavailability of PEA by times 1.75 compared to standard PEA.
x1.75 More absorption compared to standard PEA
Levagen+® Bioavailability Study available for download.
